news Cilcare featured in MedNous Journal: “The challenge of treating hearing loss as people age” Learn More > 8 March 2024 Join Cilcare’s experts & CBSET’s partner at the ARO 2024 in Anaheim Learn More > 15 January 2024 New publication from Cilcare & Pasteur Institute reveals breakthroughs in mice models’ central auditory processing of neurological disorders Learn More > 17 November 2023 Hearing Therapeutics Summit 2023: Watch Cilcare’s recorded presentation ! Learn More > 14 November 2023 Meet CILcare-CBSET at the Safety Pharmacology Society annual meeting in Brussels Learn More > 31 July 2023 CILcare to attend the IEB in London and give a presentation on cochlear synaptopathy preclinical and clinical research at the Hearing Therapeutics Summit Learn More > 31 July 2023 CILcare featured in EACCNY’s “Future of Technology” podcast Learn More > 12 July 2023 CILcare announces appointment of Alain Chatelin, acting as Chief Medical Officer Learn More > 10 July 2023 New milestone achieved by CILcare to demonstrate the importance of auditory signatures as new marker of neuro-inflammatory diseases Learn More > 3 July 2023 « Previous Page1 Page2 Page3 … Page23 Next »
Cilcare featured in MedNous Journal: “The challenge of treating hearing loss as people age” Learn More > 8 March 2024
New publication from Cilcare & Pasteur Institute reveals breakthroughs in mice models’ central auditory processing of neurological disorders Learn More > 17 November 2023
Hearing Therapeutics Summit 2023: Watch Cilcare’s recorded presentation ! Learn More > 14 November 2023
Meet CILcare-CBSET at the Safety Pharmacology Society annual meeting in Brussels Learn More > 31 July 2023
CILcare to attend the IEB in London and give a presentation on cochlear synaptopathy preclinical and clinical research at the Hearing Therapeutics Summit Learn More > 31 July 2023
CILcare announces appointment of Alain Chatelin, acting as Chief Medical Officer Learn More > 10 July 2023
New milestone achieved by CILcare to demonstrate the importance of auditory signatures as new marker of neuro-inflammatory diseases Learn More > 3 July 2023